Service de Gynécologie - Hôpital de la Croix-Rousse - Hospices Civils de Lyon
Lyon, 69004, France
NCT Number: NCT03777397
Breast cancer is the most common cancer in French women, with 52000 new cases each year.
Shift work and night work is recognized by International Agency for Research on Cancer as a potential risk factor. Epidemiological studies find, for most of them, an increased risk of breast cancer compared with general population. Physiological hypothesis rely on the melatonin role in defense against tumorigenesis.
According to High Authority of Health clinical good practice guidelines, the risk does not justify more screening than the organized screening. We do not have information about awareness level of workers in health structures, specially in the Hospices Civils de Lyon.
Investigators would like to know how employees take part to breast cancer screening, specially in night workers.
This study, as a survey, is a first step to evaluate the need for specific actions to increase the participation to breast cancer screening.
Looking for future studies?
Notify Me18 year–70 year
Female
Observational
Lyon, 69004, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Questionnaire on the level of awareness of this risk among health sector employees, and more specifically the Lyon Civilian Hospices, and on participation in breast cancer screening for HCL employees, particularly among night shift staff.
Time frame: 5 minutes
One question of the questionnaire is about this participation
Hospices Civils de Lyon
Other
Study of Awareness of Hospices Civils de Lyon Workers About Breast Cancer Screening
Acronym: DEPSEIN_HCL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT05754658
Breast Cancer, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07040514
Breast Cancer, Breast Diseases
Lebanon, New Hampshire, United States
View Trial DetailsNCT06604858
Breast Cancer, Breast Diseases
A Coruña, Spain
View Trial Details